MORE►
dodo
Beth Shapiro, Ph.D., chief science officer at Colossal Biosciences [Photo: Business Wire]
Colossal Announces $7.5M in New Investments in Ancient DNA Academic Research
by Lance Murray | Apr 17, 2024
Colossal Biosciences’ academic investments include partnerships with Stockholm University, the University of Potsdam, the University of California Santa Cruz, the University of Alaska, McMaster University, University of Copenhagen, and Rowan University, among others.
by Lance Murray |
May 19, 2023
Last year, the partnership announced a near complete sequence of the Asian elephant genome. Colossal and VGP said the sequencing work is part of a long-term effort to ensure the survival of elephant species in the face of climate change, deforestation, and disease.
MORE►
by David Seeley |
Jan 31, 2023
Colossal says its efforts could help boost "the U.S. high-tech advantage." Its gene editing technologies "will make waves across sectors—in agriculture with new biofuels and preserving biodiversity, as well as in human health through improved gene therapy and vaccine development," the company said.
MORE►
